Financhill
Back

Vaxcyte Quote, Financials, Valuation and Earnings

Vaxcyte Price Quote

$86.52
-0.05 (0.36%)
(Updated: December 21, 2024 at 5:41 AM ET)

Vaxcyte Key Stats

Sell
30
Vaxcyte (PCVX) is a Sell

Day range:
$86.26 - $88.90
52-week range:
$53.83 - $121.06
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.16%

Volume:
3.7M
Avg. volume:
1.5M
1-year change:
45.42%
Market cap:
$10.8B
Revenue:
$0
EPS:
$-4.6

How Much Does Vaxcyte Make?

Data Unavailable

Is Vaxcyte Growing As A Company?

Data Unavailable

Vaxcyte Stock Price Performance

  • Did Vaxcyte Stock Go Up Last Month?
    Vaxcyte share price went up by 0.71% last month
  • Did PCVX's Share Price Rise Over The Last Year?
    PCVX share price rose by 45.42% over the past 1 year

What Is Vaxcyte 52-Week High & Low?

  • What Is Vaxcyte’s 52-Week High Share Price?
    Vaxcyte has traded as high as $121.06 over the past 52 weeks
  • What Is Vaxcyte’s 52-Week Low Share Price?
    Vaxcyte has traded as low as $53.83 over the past 52 weeks

Vaxcyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vaxcyte?

Data Unavailable

Is Vaxcyte Cash Flow Positive?

Data Unavailable

Vaxcyte Return On Invested Capital

Data Unavailable

Vaxcyte Earnings Date & Stock Price

  • What Is Vaxcyte's Stock Price Today?
    A single share of PCVX can be purchased today for 86.57
  • What Is Vaxcyte’s Stock Symbol?
    Vaxcyte trades on the nasdaq under the ticker symbol: PCVX
  • When Is Vaxcyte’s Next Earnings Date?
    The next quarterly earnings date for Vaxcyte is scheduled on February 27, 2025
  • When Is PCVX's next ex-dividend date?
    Vaxcyte's next ex-dividend date is December 21, 2024
  • How To Buy Vaxcyte Stock?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Vaxcyte Competitors

  • Who Are Vaxcyte's Competitors?
    Below is a list of companies who compete with Vaxcyte or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Vaxcyte Dividend Yield

Data Unavailable

Vaxcyte Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.13%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 149.89
Upside from Last Price: 73.14%

Major Shareholders

Data Unavailable